Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTreatt Regulatory News (TET)

Share Price Information for Treatt (TET)

Share Price is delayed by 15 minutes
Get Live Data
303.50    0.00 (0.00%)
Bid:
303.50
Ask:
304.00
Spread: 0.50 (0.165%)
Market Cap: £179.17m
TET Live PriceLast checked at - London Stock Exchange

Intraday Treatt Share Chart

Form 8.3 - Treatt plc - Amendment

9 Sep 2025 16:46

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:

GAMCO Investors, Inc.

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Treatt plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

September 8, 2025

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

NO

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

Ordinary

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

347,585

0.59

(2) Cash-settled derivatives:

280,000

0.47

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

TOTAL:

627,585

1.06

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security

Purchase/sale

Number of securities

Price per unit

(GBp)

(b) Cash-settled derivative transactions

Date

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

(GBp)

9/8/25

Ordinary

CFD

Increasing long position

280,000

264.74

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

September 9, 2025

Contact name:

David Goldman

Telephone number:

914-921-7793

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’sMarket Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250909644438/en/

Copyright Business Wire 2025

Date   Source Headline
13th Jun 201810:14 amRNSDirector/PDMR Shareholding
11th Jun 20184:47 pmRNSHolding(s) in Company
8th Jun 20187:00 amRNSBlock Listing Application
5th Jun 201812:07 pmRNSBlock Listing Six Monthly Return - Replacement
4th Jun 20185:00 pmRNSHolding(s) in Company
4th Jun 201810:42 amRNSBlock Listing Six Monthly Return
1st Jun 201811:30 amRNSTotal Voting Rights
1st Jun 201811:24 amRNSHolding(s) in Company
31st May 20183:50 pmRNSCompletion of disposal
18th May 201811:13 amRNSDirector/PDMR Shareholding
11th May 20184:50 pmRNSDirector/PDMR Shareholding
8th May 20187:19 amRNSHalf-year Report
8th May 20187:15 amRNSDisposal
30th Apr 201812:20 pmRNSTotal Voting Rights and Capital
27th Apr 20184:39 pmRNSHolding(s) in Company
11th Apr 20183:56 pmRNSHolding(s) in Company
6th Apr 20181:31 pmRNSHolding(s) in Company
5th Apr 20187:00 amRNSTrading Update
26th Mar 20184:41 pmRNSDirector/PDMR Shareholding
26th Mar 20184:41 pmRNSDirector/PDMR Shareholding
5th Mar 20183:03 pmRNSDirector/PDMR Shareholding
8th Feb 20183:08 pmRNSHolding(s) in Company
26th Jan 20184:32 pmRNSResult of AGM
25th Jan 20181:47 pmRNSHolding(s) in Company
29th Dec 20177:00 amRNSVoting Rights and Captial
22nd Dec 20179:01 amRNSHolding(s) in Company
21st Dec 20173:23 pmRNSHolding(s) in Company
19th Dec 20173:46 pmRNSDirector/PDMR Shareholding
19th Dec 20173:20 pmRNSHolding(s) in Company
18th Dec 20173:41 pmRNSResult of General Meeting
14th Dec 201710:41 amRNSAnnual Financial Report
6th Dec 20175:04 pmRNSHolding(s) in Company
1st Dec 20174:16 pmRNSBlock Listing Six Monthly Return
1st Dec 20177:00 amRNSTotal Voting Rights
28th Nov 20177:00 amRNSPlacing to raise £21.6 million
28th Nov 20177:00 amRNSFinal Results
10th Nov 201712:34 pmRNSHolding(s) in Company
2nd Oct 20177:00 amRNSTrading Update
29th Sep 20175:14 pmRNSTotal Voting Rights
26th Sep 20178:54 amRNSHolding(s) in Company
21st Sep 201712:23 pmRNSHolding(s) in Company
21st Aug 201711:09 amRNSDirector/PDMR Shareholding
2nd Aug 20175:07 pmRNSTotal Voting Rights
20th Jul 20171:50 pmRNSDirector/PDMR Shareholding
5th Jun 20171:35 pmRNSBlock Listing Six Monthly Return
23rd May 20179:30 amRNSBlock Listing Application
11th May 20174:05 pmRNSHolding(s) in Company
11th May 20174:01 pmRNSDirector/PDMR Shareholding
10th May 20172:53 pmRNSHolding(s) in Company
9th May 20177:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.